New NIH Omnibus SBIR/STTR Solicitations Are Out
The National Institutes of Health (NIH) releases annual Omnibus Solicitations for its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. These solicitations are the most flexible SBIR/STTR opportunities at NIH, as they allow small businesses to propose their own unique R&D efforts that align with at least one of NIH’s wide-ranging research interests.
Last January, we noted various changes to the solicitations according to the SBIR/STTR Reauthorization Act of 2011, and we identified the additional changes when the solicitations were re-issued in May. More changes have been implemented in 2014.
For the 2014 solicitations, one of the major changes is that a small business may apply for a Phase II SBIR when the previous award was a Phase I STTR, and vice versa. NIH notes that the Omnibus Solicitations will not accept “Direct Phase II” submissions, but some upcoming special solicitations may allow it.
Additionally, NIH has received a waiver from the Small Business Association (SBA) for the budget to exceed the hard caps for specific topics. Finally, the special eligibility rules that allow venture capital operating companies to own more than 50% of the small business has been extended to Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), and Administration for Children and Families (ACF) applications.
For more information on the SBIR and STTR Omnibus Solicitations please refer to:http://ift.tt/1jUe5un
To see if your research aligns with any of the NIH, CDC, FDA, or ACF programs, and to see what topics may exceed the hard budget caps, please refer to: http://ift.tt/19ZsGRT
Contact Mike Grenier at 281-558-7100 or MGrenier@ParadigmLP.com
to learn more about various grant opportunities.